CIK 0000921299 · Non-accelerated filer<br>Smaller reporting company
KYNTRA BIO, INC.
Sign in to watch- Ticker
- KYNB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 770357827
- Phone
- 415-978-1200
- Business address
- 350 BAY STREET, SUITE 100 #6009, SAN FRANCISCO, CA, 94133
- Former names
- FIBROGEN INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-08-30 | Chung Christine SVP, China Operations | Grant or award · Stock Option (Right to Buy) | +220,000 | 220,000 | ||
| 2023-08-10 | Schoeneck James A Director | Grant or award · Stock Option (Right to Buy) | +10,000 | 10,000 | ||
| 2023-08-07 | Wettig Thane Chief Commercial Officer | Grant or award | +200,000 | 308,261 | ||
| 2023-08-07 | Wettig Thane Chief Commercial Officer | Grant or award · Stock Option (Right to Buy) | +300,000 | 300,000 | ||
| 2023-08-04 | Henderson Jeffrey William Director | Sale 10b5-1 | −2,000 | $1.91 | $4K | 30,866 |
| 2023-07-11 | Henderson Jeffrey William Director | Sale 10b5-1 | −2,000 | $2.69 | $5K | 32,866 |
| 2023-07-07 | Conterno Enrique A Chief Executive Officer | Sale | −1,880 | $2.80 | $5K | 374,722 |
| 2023-06-23 | Wettig Thane Chief Commercial Officer | Sale | −791 | $16.53 | $13K | 108,261 |
| 2023-06-14 | Chung Christine SVP, China Operations | Sale 10b5-1 | −5,250 | $16.66 | $87K | 237,327 |
| 2023-06-14 | Chung Christine SVP, China Operations | Sale 10b5-1 | −1,000 | $17.46 | $17K | 236,327 |
| 2023-06-13 | Chung Christine SVP, China Operations | Sale 10b5-1 | −6,250 | $17.60 | $110K | 242,577 |
| 2023-06-09 | Cravatt Benjamin Director | Sale 10b5-1 | −1,766 | $16.75 | $30K | 30,914 |
| 2023-06-09 | Cravatt Benjamin Director | Sale 10b5-1 | −2,178 | $17.51 | $38K | 28,736 |
| 2023-06-09 | Brennan Aoife Director | Sale 10b5-1 | −1,994 | $16.74 | $33K | 30,686 |
| 2023-06-09 | Brennan Aoife Director | Sale 10b5-1 | −2,739 | $17.52 | $48K | 27,947 |
| 2023-06-09 | Blaug Suzanne Director | Sale 10b5-1 | −3,351 | $16.73 | $56K | 34,763 |
| 2023-06-09 | Blaug Suzanne Director | Sale 10b5-1 | −5,169 | $17.51 | $91K | 29,594 |
| 2023-06-09 | EDWARDS JEFFREY L Director | Sale 10b5-1 | −3,265 | $16.74 | $55K | 38,601 |
| 2023-06-09 | EDWARDS JEFFREY L Director | Sale 10b5-1 | −4,624 | $17.51 | $81K | 33,977 |
| 2023-06-08 | Ho Maykin Director | Sale 10b5-1 | −2,295 | $16.79 | $39K | 37,726 |
Page 6 of 8 · 156 trades